Sanara MedTech (SMTI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting called to order by the CEO, held virtually to facilitate shareholder participation.
Rules of procedure posted online; participants asked to follow them.
Chairman and secretary roles assigned; inspector of election appointed.
Agenda included election of directors, ratification of auditor, advisory votes on executive compensation, and other business.
Board and executive committee updates
Current board members introduced at the start of the meeting.
Nine director nominees listed for election, each to serve until the 2027 annual meeting.
Shareholder proposals
Shareholders voted on four main proposals: election of directors, ratification of auditor, approval of executive compensation, and frequency of future advisory votes on compensation.
Latest events from Sanara MedTech
- Q2 2026 revenue rose 9% to $28.1M with a 93% gross margin and a merger deal with MiMedx announced.SMTI
Q2 2026 - Record revenue and high margins reflect a focused, innovation-driven surgical solutions strategy.SMTI
Investor presentation - Focused on surgical wound care, the company projects strong growth and new product launches.SMTI
TD Cowen 46th Annual Health Care Conference - Q1 2026 revenue rose 19% to $27.8M, with net income of $0.4M and strong gross margin of 93%.SMTI
Q1 2026 - New Lead Independent Director and Compensation Committee chair appointed, with updated compensation.SMTI
Proxy filing - Annual Meeting to vote on directors, auditor, and executive pay, with board recommendations.SMTI
Proxy filing - Virtual annual meeting to vote on directors, auditor, executive pay, and governance matters.SMTI
Proxy filing - Strong Q2 growth, expanded leadership, and a robust product pipeline position the company for future success.SMTI
Cantor Global Healthcare Conference 2025 - Q1 2025 revenue up 26% to $23.4M, margin and EBITDA gains, net loss widens, cash at $20.7M.SMTI
Q1 2025